101 related articles for article (PubMed ID: 15650051)
21. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
22. The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis.
Hosen N; Shirakata T; Nishida S; Yanagihara M; Tsuboi A; Kawakami M; Oji Y; Oka Y; Okabe M; Tan B; Sugiyama H; Weissman IL
Leukemia; 2007 Aug; 21(8):1783-91. PubMed ID: 17525726
[TBL] [Abstract][Full Text] [Related]
23. Cloning and characterization of the novel chimeric gene TEL/PTPRR in acute myelogenous leukemia with inv(12)(p13q13).
Nakamura F; Nakamura Y; Maki K; Sato Y; Mitani K
Cancer Res; 2005 Aug; 65(15):6612-21. PubMed ID: 16061641
[TBL] [Abstract][Full Text] [Related]
24. Signal transduction and cellular functions of the TEL/ARG oncoprotein.
Okuda K; Oda A; Sato Y; Nakayama A; Fujita H; Sonoda Y; Griffin JD
Leukemia; 2005 Apr; 19(4):603-10. PubMed ID: 15729383
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity to imatinib but low frequency of the TEL/PDGFRbeta fusion protein in chronic myelomonocytic leukemia.
Gunby RH; Cazzaniga G; Tassi E; Le Coutre P; Pogliani E; Specchia G; Biondi A; Gambacorti-Passerini C
Haematologica; 2003 Apr; 88(4):408-15. PubMed ID: 12681968
[TBL] [Abstract][Full Text] [Related]
26. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
27. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
28. Searching for leukemia stem cells--not yet the end of the road?
Jordan CT
Cancer Cell; 2006 Oct; 10(4):253-4. PubMed ID: 17045202
[TBL] [Abstract][Full Text] [Related]
29. Expression of the TEL-Syk fusion protein in hematopoietic stem cells leads to rapidly fatal myelofibrosis in mice.
Graham MT; Abram CL; Hu Y; Lowell CA
PLoS One; 2013; 8(10):e77542. PubMed ID: 24116232
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis for Flk1 expression in hemato-cardiovascular progenitors in the mouse.
Ishitobi H; Wakamatsu A; Liu F; Azami T; Hamada M; Matsumoto K; Kataoka H; Kobayashi M; Choi K; Nishikawa S; Takahashi S; Ema M
Development; 2011 Dec; 138(24):5357-68. PubMed ID: 22071109
[TBL] [Abstract][Full Text] [Related]
31. Positive and negative regulatory roles of the WW-like domain in TEL-PDGFbetaR transformation.
Chen J; Williams IR; Kutok JL; Duclos N; Anastasiadou E; Masters SC; Fu H; Gilliland DG
Blood; 2004 Jul; 104(2):535-42. PubMed ID: 15054045
[TBL] [Abstract][Full Text] [Related]
32. Tel-med.
Msmw
West J Med; 1979 Aug; 131(2):137-8. PubMed ID: 18748460
[No Abstract] [Full Text] [Related]
33. Revisiting NTRKs as an emerging oncogene in hematological malignancies.
Joshi SK; Davare MA; Druker BJ; Tognon CE
Leukemia; 2019 Nov; 33(11):2563-2574. PubMed ID: 31551508
[TBL] [Abstract][Full Text] [Related]
34. A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report.
Chen S; Nagel S; Schneider B; Dai H; Geffers R; Kaufmann M; Meyer C; Pommerenke C; Thress KS; Li J; Quentmeier H; Drexler HG; MacLeod RAF
Cell Oncol (Dordr); 2018 Feb; 41(1):93-101. PubMed ID: 29119387
[TBL] [Abstract][Full Text] [Related]
35. Amplification of mixed lineage leukemia gene perturbs hematopoiesis and cooperates with partial tandem duplication to induce acute myeloid leukemia.
Yip BH; Tsai CT; Rane JK; Vetharoy W; Anguita E; Dong S; Caligiuri MA; So CWE
Haematologica; 2017 Aug; 102(8):e300-e304. PubMed ID: 28522575
[No Abstract] [Full Text] [Related]
36. Characterization of a Fetal Liver Cell Population Endowed with Long-Term Multiorgan Endothelial Reconstitution Potential.
Cañete A; Comaills V; Prados I; Castro AM; Hammad S; Ybot-Gonzalez P; Bockamp E; Hengstler JG; Gottgens B; Sánchez MJ
Stem Cells; 2017 Feb; 35(2):507-521. PubMed ID: 27615355
[TBL] [Abstract][Full Text] [Related]
37. A novel mode of enhancer evolution: the Tal1 stem cell enhancer recruited a MIR element to specifically boost its activity.
Smith AM; Sanchez MJ; Follows GA; Kinston S; Donaldson IJ; Green AR; Göttgens B
Genome Res; 2008 Sep; 18(9):1422-32. PubMed ID: 18687876
[TBL] [Abstract][Full Text] [Related]
38. Somatic stem cells and the origin of cancer.
Martínez-Climent JA; Andreu EJ; Prosper F
Clin Transl Oncol; 2006 Sep; 8(9):647-63. PubMed ID: 17005467
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional link between blood and bone: the stem cell leukemia gene and its +19 stem cell enhancer are active in bone cells.
Pimanda JE; Silberstein L; Dominici M; Dekel B; Bowen M; Oldham S; Kallianpur A; Brandt SJ; Tannahill D; Göttgens B; Green AR
Mol Cell Biol; 2006 Apr; 26(7):2615-25. PubMed ID: 16537906
[TBL] [Abstract][Full Text] [Related]
40. Directing oncogenic fusion genes into stem cells via an SCL enhancer.
Eguchi M; Eguchi-Ishimae M; Green A; Enver T; Greaves M
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1133-8. PubMed ID: 15650051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
